• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新处方氯氮平的精神分裂症和分裂情感障碍患者再入院风险。

Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine.

机构信息

1 King's College London, Institute of Psychiatry Psychology and Neuroscience, London, UK.

2 National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre, London, UK.

出版信息

J Psychopharmacol. 2019 Apr;33(4):449-458. doi: 10.1177/0269881118817387. Epub 2019 Jan 8.

DOI:10.1177/0269881118817387
PMID:30616489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6431783/
Abstract

BACKGROUND

Insight into the effect of clozapine is limited by a lack of controlling for confounding variables in current research. Our objective was to investigate the association between clozapine prescribed at discharge, following an inpatient episode, and risk of readmission into secondary mental health services in patients with schizophrenia and schizoaffective disorder, controlling extensively for confounding variables.

METHODS

Clinical records from 3651 patients were analysed in a retrospective observational cohort study. Cox proportional-hazards regression models were used to assess the risk of hospital readmission. A series of sensitivity analyses were also conducted. Propensity score methods were used to address confounding-by-indication.

RESULTS

Patients on clozapine ( n=202) had a reduced risk of readmission compared with patients on other antipsychotics (adjusted hazard ratio=0.79; 95% confidence interval: 0.64-0.99; p=0.043). Clozapine also had a protective effect on risk of readmission when compared with olanzapine (adjusted hazard ratio 0.76; 95% confidence interval: 0.60-0.96; p=0.021). The effect size remained consistent after adjusting for an array of possible confounders, as well as using propensity scores to address confounding-by-indication. A statistically significant result was also noted in all but two sensitivity analyses.

CONCLUSION

Our findings suggest that clozapine is associated with a reduced risk of readmission into secondary mental health services.

摘要

背景

目前的研究由于缺乏对混杂变量的控制,对氯氮平的作用了解有限。我们的目的是在控制了广泛的混杂变量的情况下,研究精神分裂症和分裂情感障碍患者在住院期间开出的氯氮平与随后在二级精神卫生服务机构再次入院的风险之间的关系。

方法

在一项回顾性观察队列研究中,对 3651 名患者的临床记录进行了分析。使用 Cox 比例风险回归模型评估了住院再入院的风险。还进行了一系列敏感性分析。采用倾向评分法来解决混杂因素。

结果

与使用其他抗精神病药物的患者相比(调整后的危险比=0.79;95%置信区间:0.64-0.99;p=0.043),使用氯氮平的患者再入院的风险降低。与奥氮平相比,氯氮平对再入院风险也有保护作用(调整后的危险比 0.76;95%置信区间:0.60-0.96;p=0.021)。在调整了一系列可能的混杂因素后,以及使用倾向评分来解决混杂因素后,该效果大小仍然一致。除了两项敏感性分析外,其他所有分析均得出了统计学显著的结果。

结论

我们的研究结果表明,氯氮平与二级精神卫生服务机构的再入院风险降低相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef4/6431783/de7e26a9ce2d/10.1177_0269881118817387-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef4/6431783/0ed4047e4593/10.1177_0269881118817387-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef4/6431783/de7e26a9ce2d/10.1177_0269881118817387-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef4/6431783/0ed4047e4593/10.1177_0269881118817387-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef4/6431783/de7e26a9ce2d/10.1177_0269881118817387-fig2.jpg

相似文献

1
Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine.新处方氯氮平的精神分裂症和分裂情感障碍患者再入院风险。
J Psychopharmacol. 2019 Apr;33(4):449-458. doi: 10.1177/0269881118817387. Epub 2019 Jan 8.
2
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.抗精神病药物治疗对首次因精神分裂症和分裂情感性障碍住院后接受社区护理的全国队列患者的有效性:观察性随访研究。
BMJ. 2006 Jul 29;333(7561):224. doi: 10.1136/bmj.38881.382755.2F. Epub 2006 Jul 6.
3
The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders.氯氮平对过早死亡率的影响:临床监测及其他潜在混杂因素的评估
Schizophr Bull. 2015 May;41(3):644-55. doi: 10.1093/schbul/sbu120. Epub 2014 Aug 25.
4
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.29823例精神分裂症患者全国队列中抗精神病药物治疗的真实世界有效性
JAMA Psychiatry. 2017 Jul 1;74(7):686-693. doi: 10.1001/jamapsychiatry.2017.1322.
5
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.在精神分裂症自然主义治疗中停用非典型抗精神病药物与典型抗精神病药物的时间。
BMC Psychiatry. 2006 Feb 21;6:8. doi: 10.1186/1471-244X-6-8.
6
Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.氯氮平治疗难治性精神分裂症、分裂情感性障碍或精神病性双相障碍患者:一项48个月的自然随访研究。
J Clin Psychiatry. 2003 Apr;64(4):451-8. doi: 10.4088/jcp.v64n0416.
7
Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.氯氮平与标准抗精神病药物治疗成人精神分裂症的疗效比较。
Am J Psychiatry. 2016 Feb 1;173(2):166-73. doi: 10.1176/appi.ajp.2015.15030332. Epub 2015 Nov 6.
8
Second-Generation Antipsychotics and Pneumonia-Related Hospitalizations.第二代抗精神病药物与肺炎相关的住院治疗。
Prim Care Companion CNS Disord. 2020 Aug 6;22(4):20m02594. doi: 10.4088/PCC.20m02594.
9
Assessment of treatment outcomes and associated factors among patients treated with clozapine at amanuel mental specialized hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴阿马努埃尔精神专科医院接受氯氮平治疗患者的治疗结果及相关因素评估。
PLoS One. 2025 Apr 16;20(4):e0321536. doi: 10.1371/journal.pone.0321536. eCollection 2025.
10
Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.氯氮平在常规临床实践中延迟住院的有效性:一项为期2年的观察性研究。
Psychopharmacol Bull. 2010;43(2):67-81.

引用本文的文献

1
Clozapine, relapse, and adverse events: a 10-year electronic cohort study in Canada.氯氮平、复发及不良事件:加拿大一项为期10年的电子队列研究
Br J Psychiatry. 2024 Dec;225(6):572-578. doi: 10.1192/bjp.2024.140.
2
CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.CLEAR-氯氮平治疗早期精神病:一项多中心、随机对照试验的研究方案,比较氯氮平与其他抗精神病药治疗真实世界环境中治疗抵抗性精神分裂症青年患者的疗效。
BMC Psychiatry. 2024 Feb 14;24(1):122. doi: 10.1186/s12888-023-05397-1.
3

本文引用的文献

1
Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.氯氮平治疗抵抗性精神分裂症相关的死亡率和自伤行为。
Am J Psychiatry. 2017 Oct 1;174(10):990-998. doi: 10.1176/appi.ajp.2017.16091097. Epub 2017 Jul 28.
2
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.29823例精神分裂症患者全国队列中抗精神病药物治疗的真实世界有效性
JAMA Psychiatry. 2017 Jul 1;74(7):686-693. doi: 10.1001/jamapsychiatry.2017.1322.
3
The impact of clozapine on hospital use: a systematic review and meta-analysis.
Examining racial disparity in psychotic disorders related ambulatory care visits: an observational study using national ambulatory medical care survey 2010-2015.
考察与精神病相关的门诊就诊中的种族差异:使用 2010-2015 年全国门诊医疗调查的观察性研究。
BMC Psychiatry. 2023 Aug 17;23(1):601. doi: 10.1186/s12888-023-05095-y.
4
Ethnic disparities in clozapine prescription for service-users with schizophrenia-spectrum disorders: a systematic review.精神分裂症谱系障碍患者氯氮平处方的种族差异:系统评价。
Psychol Med. 2022 Sep;52(12):2212-2223. doi: 10.1017/S0033291722001878. Epub 2022 Jul 5.
5
Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records.使用电子临床记录数据的回顾性队列研究:氯氮平在治疗抵抗性精神分裂症患者中的使用与种族差异。
Soc Psychiatry Psychiatr Epidemiol. 2022 Jul;57(7):1341-1355. doi: 10.1007/s00127-022-02257-3. Epub 2022 Mar 4.
6
Efficacy of clozapine for long-stay patients with treatment-resistant schizophrenia: 4-year observational study.氯氮平治疗长期住院治疗抵抗性精神分裂症患者的疗效:4 年观察研究。
Neuropsychopharmacol Rep. 2022 Jun;42(2):183-190. doi: 10.1002/npr2.12244. Epub 2022 Mar 2.
7
Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine.使用统计学习方法识别氯氮平反应的社会人口统计学和临床预测因素。
J Psychopharmacol. 2022 Apr;36(4):498-506. doi: 10.1177/02698811221078746. Epub 2022 Feb 25.
8
COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine.新冠相关住院、重症治疗和氯氮平治疗精神分裂症患者的全因死亡率。
Eur Neuropsychopharmacol. 2022 Mar;56:92-99. doi: 10.1016/j.euroneuro.2022.01.007. Epub 2022 Jan 24.
9
A Misdiagnosed Case of Schizoaffective Disorder With Bipolar Manifestations.一例误诊为伴有双相表现的分裂情感性障碍的病例。
Cureus. 2021 Jul 28;13(7):e16686. doi: 10.7759/cureus.16686. eCollection 2021 Jul.
10
Impact of the COVID-19 pandemic on remote mental healthcare and prescribing in psychiatry: an electronic health record study.新冠疫情对精神科远程精神医疗保健和处方的影响:一项电子健康记录研究。
BMJ Open. 2021 Mar 30;11(3):e046365. doi: 10.1136/bmjopen-2020-046365.
氯氮平对住院治疗的影响:一项系统评价与荟萃分析。
Acta Psychiatr Scand. 2017 Apr;135(4):296-309. doi: 10.1111/acps.12700. Epub 2017 Feb 3.
4
Factors associated with changes in hospitalisation in patients prescribed clozapine.与服用氯氮平患者住院情况变化相关的因素。
J Psychopharmacol. 2016 Aug;30(8):819-25. doi: 10.1177/0269881116642745. Epub 2016 Apr 19.
5
Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource.南伦敦和莫兹利国民保健服务基金会信托生物医学研究中心(SLaM BRC)病例登记册的队列概况:源自电子心理健康记录的数据资源的现状及近期改进
BMJ Open. 2016 Mar 1;6(3):e008721. doi: 10.1136/bmjopen-2015-008721.
6
Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia.氯氮平治疗老年慢性难治性精神分裂症的有效性和安全性
Int Psychogeriatr. 2015 Jan;27(1):131-4. doi: 10.1017/S1041610214001756. Epub 2014 Aug 28.
7
The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders.氯氮平对过早死亡率的影响:临床监测及其他潜在混杂因素的评估
Schizophr Bull. 2015 May;41(3):644-55. doi: 10.1093/schbul/sbu120. Epub 2014 Aug 25.
8
Getting more out of biomedical documents with GATE's full lifecycle open source text analytics.利用 GATE 的全生命周期开源文本分析技术,从生物医学文档中获取更多信息。
PLoS Comput Biol. 2013;9(2):e1002854. doi: 10.1371/journal.pcbi.1002854. Epub 2013 Feb 7.
9
Clozapine's role in the treatment of first-episode schizophrenia.氯氮平在首发精神分裂症治疗中的作用。
Am J Psychiatry. 2013 Feb;170(2):146-51. doi: 10.1176/appi.ajp.2012.12060778.
10
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study.精神分裂症患者的合并症和死亡率:一项瑞典全国队列研究。
Am J Psychiatry. 2013 Mar;170(3):324-33. doi: 10.1176/appi.ajp.2012.12050599.